Lung Fung Group Appears Poised to Benefit from Demand Tailwinds

Dow Jones07-22 15:32

0732 GMT - Lung Fung Group seems poised to benefit from structural demand tailwinds, gaining the Hong Kong-based pharmaceutical retailer a new bull at DBS Group Research. Structural drivers, including ageing demographics and rising preventive healthcare awareness, continue to expand Lung Fung's addressable markets, she says. The analyst estimates the city's beauty and health product markets to grow at a 8.1% compound annual growth rate and 5.2% CAGR, respectively, by 2029. Lung Fung's supply-chain differentiation should boost its pricing power, while its private label portfolio likely reinforces customer stickiness, she adds. DBS starts its coverage with a buy rating and 7.98 Hong Kong dollar target price. Shares rise 5.7% to HK$3.92. (megan.cheah@wsj.com)

(END) Dow Jones Newswires

July 22, 2026 03:32 ET (07:32 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2653377897?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-22 15:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2653377897","market":"us","top_or_hot":-1,"title":"Lung Fung Group Appears Poised to Benefit from Demand Tailwinds","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0732 GMT - Lung Fung Group seems poised to benefit from structural demand tailwinds, gaining the Hong Kong-based pharmaceutical retailer a new bull at DBS Group Research. Structural drivers, including ageing demographics and rising preventive healthcare awareness, continue to expand Lung Fung's addressable markets, she says. The analyst estimates the city's beauty and health product markets to grow at a 8.1% compound annual growth rate and 5.2% CAGR, respectively, by 2029. Lung Fung's supply-chain differentiation should boost its pricing power, while its private label portfolio likely reinforces customer stickiness, she adds. DBS starts its coverage with a buy rating and 7.98 Hong Kong dollar target price. Shares rise 5.7% to HK$3.92. (megan.cheah@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 22, 2026 03:32 ET (07:32 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lung Fung Group Appears Poised to Benefit from Demand Tailwinds</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLung Fung Group Appears Poised to Benefit from Demand Tailwinds\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-07-22 15:32</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0732 GMT - Lung Fung Group seems poised to benefit from structural demand tailwinds, gaining the Hong Kong-based pharmaceutical retailer a new bull at DBS Group Research. Structural drivers, including ageing demographics and rising preventive healthcare awareness, continue to expand Lung Fung's addressable markets, she says. The analyst estimates the city's beauty and health product markets to grow at a 8.1% compound annual growth rate and 5.2% CAGR, respectively, by 2029. Lung Fung's supply-chain differentiation should boost its pricing power, while its private label portfolio likely reinforces customer stickiness, she adds. DBS starts its coverage with a buy rating and 7.98 Hong Kong dollar target price. Shares rise 5.7% to HK$3.92. (megan.cheah@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 22, 2026 03:32 ET (07:32 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1247","symbol_name":"药品零售","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2653377897","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2653377897","pubTimestamp":1784705520,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0732 GMT - Lung Fung Group seems poised to benefit from structural demand tailwinds, gaining the Hong Kong-based pharmaceutical retailer a new bull at DBS Group Research. Structural drivers, including ageing demographics and rising preventive healthcare awareness, continue to expand Lung Fung's addressable markets, she says. The analyst estimates the city's beauty and health product markets to grow at a 8.1% compound annual growth rate and 5.2% CAGR, respectively, by 2029. Lung Fung's supply-chain differentiation should boost its pricing power, while its private label portfolio likely reinforces customer stickiness, she adds. DBS starts its coverage with a buy rating and 7.98 Hong Kong dollar target price. Shares rise 5.7% to HK$3.92.  Dow Jones NewswiresJuly 22, 2026 03:32 ET Copyright  2026 Dow Jones & Company, Inc.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1247":"药品零售","02290":"龙丰集团"},"translate_title":"龙丰集团似乎有望从需求顺风中受益","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02290":1.95},"content_text":"0732 GMT - Lung Fung Group seems poised to benefit from structural demand tailwinds, gaining the Hong Kong-based pharmaceutical retailer a new bull at DBS Group Research. Structural drivers, including ageing demographics and rising preventive healthcare awareness, continue to expand Lung Fung's addressable markets, she says. The analyst estimates the city's beauty and health product markets to grow at a 8.1% compound annual growth rate and 5.2% CAGR, respectively, by 2029. Lung Fung's supply-chain differentiation should boost its pricing power, while its private label portfolio likely reinforces customer stickiness, she adds. DBS starts its coverage with a buy rating and 7.98 Hong Kong dollar target price. Shares rise 5.7% to HK$3.92. (megan.cheah@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 22, 2026 03:32 ET (07:32 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2653377897","isCrawlerRequest":true}